Lu CH - Search Results

1

Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry.

Yeh YJ, Chao TL, Chang YJ, Chang SY, Lu CH, Chao CH, Su WC, Tseng CP, Lai MMC, Cheng JC. Yeh YJ, et al. Among authors: lu ch. Int J Mol Sci. 2023 Dec 1;24(23):17040. doi: 10.3390/ijms242317040. Int J Mol Sci. 2023. PMID: 38069363 Free PMC article.

2

CELLO2GO: a web server for protein subCELlular LOcalization prediction with functional gene ontology annotation.

Yu CS, Cheng CW, Su WC, Chang KC, Huang SW, Hwang JK, Lu CH. Yu CS, et al. Among authors: lu ch. PLoS One. 2014 Jun 9;9(6):e99368. doi: 10.1371/journal.pone.0099368. eCollection 2014. PLoS One. 2014. PMID: 24911789 Free PMC article.

3

Potent sialic acid inhibitors that target influenza A virus hemagglutinin.

Chang YJ, Yeh CY, Cheng JC, Huang YQ, Hsu KC, Lin YF, Lu CH. Chang YJ, et al. Among authors: lu ch. Sci Rep. 2021 Apr 21;11(1):8637. doi: 10.1038/s41598-021-87845-0. Sci Rep. 2021. PMID: 33883588 Free PMC article.

4

The structure-based cancer-related single amino acid variation prediction.

Liu JJ, Yu CS, Wu HW, Chang YJ, Lin CP, Lu CH. Liu JJ, et al. Among authors: lu ch. Sci Rep. 2021 Jun 30;11(1):13599. doi: 10.1038/s41598-021-92793-w. Sci Rep. 2021. PMID: 34193921 Free PMC article.

5

In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction.

Lu CH, Chung WM, Tsai CH, Cheng JC, Hsu KC, Tzeng HE. Lu CH, et al. Sci Rep. 2022 Jan 7;12(1):303. doi: 10.1038/s41598-021-03590-4. Sci Rep. 2022. PMID: 34996924 Free PMC article.

6

Predicting Anticancer Drug Resistance Mediated by Mutations.

Lin YF, Liu JJ, Chang YJ, Yu CS, Yi W, Lane HY, Lu CH. Lin YF, et al. Among authors: lu ch. Pharmaceuticals (Basel). 2022 Jan 24;15(2):136. doi: 10.3390/ph15020136. Pharmaceuticals (Basel). 2022. PMID: 35215249 Free PMC article.

7

Recognition of a Novel Gene Signature for Human Glioblastoma.

Lu CH, Wei ST, Liu JJ, Chang YJ, Lin YF, Yu CS, Chang SL. Lu CH, et al. Int J Mol Sci. 2022 Apr 9;23(8):4157. doi: 10.3390/ijms23084157. Int J Mol Sci. 2022. PMID: 35456975 Free PMC article.

8

Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 and MERS-CoV.

Chang YJ, Le UNP, Liu JJ, Li SR, Chao ST, Lai HC, Lin YF, Hsu KC, Lu CH, Lin CW. Chang YJ, et al. Among authors: lu ch. Antiviral Res. 2023 Aug;216:105653. doi: 10.1016/j.antiviral.2023.105653. Epub 2023 Jun 14. Antiviral Res. 2023. PMID: 37321487 Free PMC article.

9

The Antiviral Activity of Varenicline against Dengue Virus Replication during the Post-Entry Stage.

Lin CL, Kiu YT, Kan JY, Chang YJ, Hung PY, Lu CH, Lin WL, Hsieh YW, Kao JY, Hu NJ, Lin CW. Lin CL, et al. Among authors: lu ch. Biomedicines. 2023 Oct 11;11(10):2754. doi: 10.3390/biomedicines11102754. Biomedicines. 2023. PMID: 37893127 Free PMC article.

10

Inhibition of dengue viruses by N-methylcytisine thio derivatives through targeting viral envelope protein and NS2B-NS3 protease.

Lin CS, Lu CH, Lin TH, Kiu YT, Kan JY, Chang YJ, Hung PY, Koval'skaya AV, Tsypyshev DO, Tsypysheva IP, Lin CW. Lin CS, et al. Among authors: lu ch. Bioorg Med Chem Lett. 2024 Feb 1;99:129623. doi: 10.1016/j.bmcl.2024.129623. Epub 2024 Jan 18. Bioorg Med Chem Lett. 2024. PMID: 38242331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,614 results

Search Page

Filters